Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
MedAdvisor Limited ( (AU:AHE) ) has issued an announcement.
Adheris Health Limited has notified the market that a total of 15,862,199 options on issue have lapsed as of 31 December 2025 after the conditions attached to these securities were not, or could no longer be, satisfied. The cessation covers a large tranche of variously priced options, including several series expiring in July 2036, and results in a reduction of potential future dilution for existing shareholders while modestly simplifying the company’s capital structure.
The most recent analyst rating on (AU:AHE) stock is a Sell with a A$0.02 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:AHE Stock Forecast page.
More about MedAdvisor Limited
Adheris Health Limited, listed on the ASX under the code AHE, operates in the healthcare sector; however, this announcement provides no further detail on its specific products, services or market focus.
Average Trading Volume: 1,512,321
Technical Sentiment Signal: Sell
Current Market Cap: A$11.46M
Learn more about AHE stock on TipRanks’ Stock Analysis page.